Gregory J Post, MD in Detroit Lakes, MN - Urology

Gregory J Post, MD is a Urology physician based in Detroit Lakes, Minnesota. Gregory J Post is licensed to practice in Minnesota (license number 24719) and his current practice location is 1027 Washington Ave, Detroit Lakes, Minnesota. He can be reached at his office (for appointments etc.) via phone at (218) 847-5611.

NPI number for Gregory J Post is 1528090719 and his current mailing address is 1027 Washington Ave, Detroit Lakes, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1528090719.

Contact Information

	Gregory J Post, MD
	1027 Washington Ave, Detroit Lakes, MN 56501-3409
	(218) 847-5611
	(218) 847-0881

Physician's Profile

Full Name	Gregory J Post
Gender	Male
Speciality	Urology
Location	1027 Washington Ave, Detroit Lakes, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1528090719
Provider Enumeration Date: 07/07/2006
Last Update Date: 12/06/2011

Medical Identifiers

Medical identifiers for Gregory J Post such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528090719	NPI	-	NPPES
1528090719	Medicaid	MN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	24719 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gregory J Post is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gregory J Post, MD 1027 Washington Ave, Detroit Lakes, MN 56501-3409 Ph: (218) 847-5611	Gregory J Post, MD 1027 Washington Ave, Detroit Lakes, MN 56501-3409 Ph: (218) 847-5611

News Archive

FemSoft from Rochester Medical included in the UK Drug Tariff

Rochester Medical Corporation (Nasdaq: ROCM) today announced that the Company's FemSoft(R) Insert has been approved for inclusion in Part IX of the UK Drug Tariff as a prescription product which is reimbursable.

Osteoporosis drug may be cardioprotective in hip fracture patients

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture.

Sleep deprivation can adversely affect a person's decision-making

Gambling is a risky activity that can potentially result in the loss of a significant amount of money.

Not eating too fast associated with lower body fat levels

A study carried out in Spain reveals that certain healthy habits, like eating more than four times a day or not eating too fast, are associated with lower body fat levels independently of exercise habits during free time.

Gregory J Post, MD - Urology in Detroit Lakes, MN